Novo Nordisk targets type 2 diabetes mAbs in Xoma licensing deal
Novo Nordisk - Wikipedia
Novo Nordisk wins FDA approval for higher-dose Ozempic for adults with type 2 diabetes - Drug Discovery and Development
Novo Nordisk Diabetes and Obesity Award; applications due May 1 | OHSU Research News
Novo Nordisk wins first smart insulin pen approval for diabetes in China | BioWorld
Novo Nordisk - Home | Facebook
Novo Nordisk launches innovative treatment for diabetes in Singapore
Novo Nordisk teaming up with startups for diabetes challenge, aiming to create new digital health tools – GeekWire
Novo Nordisk's type 2 diabetes drug gets health insurance coverage < Pharma < Article - KBR
New York City FC Team Up With Novo Nordisk to Promote Diabetes Awareness and Prevention | New York City FC
Glooko Announces Collaboration with Novo Nordisk for European Connected Pen Launches - Glooko
Novo Nordisk debuts diabetes combo in Mexico - PMLiVE
Welcome to Novo Nordisk in the U.S. | Novo Nordisk U.S. Website
Diabetes and You | Diabetes Education for Patients | novoMEDLINK™
Novo Nordisk's insulin pen receives EU approval to treat type 2 diabetes
Novo Nordisk on Twitter: "Things you need to know about the #diabetes pandemic #EASD2013 http://t.co/aICjXQ4Puv http://t.co/JckcLO9DGA" / Twitter
Novo Nordisk's Type I Diabetes Research Facility, Seattle - Pharmaceutical Technology
Novo Nordisk and the University of Toronto announce a combined C$40-million investment to address diabetes and chronic disease prevention
Did Novo Illegally Use Diabetes Educators to Boost Drug Sales? | Insulin Nation
